A 2017 global update on folic acid-preventable spina bifida and anencephaly

Birth Defects Research

Volumn 110, Issue 14, 2018, Pages 1139-1147

  Kancherla, Vijaya ^a   Wagh, Kaustubh ^a   Johnson, Quentin ^b   Oakley, Godfrey P ^a  

^a EMORY UNIVERSITY   (United States)

^b Mailstop: 1599 001 1BX (SPH: Global Health)   (United States)

Author keywords

anencephaly; epidemiology; flour fortification; folic acid; prevention; spina bifida

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; BIOFORTIFICATION; CHILD; CONGENITAL MALFORMATION; CORN FLOUR; DISABILITY; FOOD INTAKE; HUMAN; INFANT MORTALITY; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; SPINAL DYSRAPHISM; WHEAT FLOUR; WORLD HEALTH ORGANIZATION; FEMALE; FOLIC ACID DEFICIENCY; FORTIFIED FOOD; INFANT; MAIZE; METABOLISM; PREGNANCY; SUPPLY AND DISTRIBUTION; WHEAT;

ANENCEPHALY; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HUMANS; INFANT; INFANT MORTALITY; PREGNANCY; PREVALENCE; SPINAL DYSRAPHISM; TRITICUM; ZEA MAYS;

EID: 85052501953     PISSN: None     EISSN: 24721727     Source Type: Journal    
DOI: 10.1002/bdr2.1366     Document Type: Article

References (33)

1. Arth, A., Kancherla, V., Pachón, H., Zimmerman, S., Johnson, Q., & Oakley, G. P., Jr. (2016). A 2015 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Research. Part A, Clinical and Molecular Teratology, 106, 520–529.
2. Beckett, E. L., Martin, C., Boyd, L., Porter, T., King, K., Niblett, S., … Lucock, M. (2017). Reduced plasma homocysteine levels in elderly Australians following mandatory folic acid fortification – A comparison of two cross-sectional cohorts. Journal of Nutrition and Metabolism, 8, 14–20.
3. Bell, K. N., & Oakley, G. P., Jr. (2006). Tracking the prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research. Part A, Clinical and Molecular Teratology, 76, 654–657.
4. Bell, K. N., & Oakley, G. P., Jr. (2009). Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research. Part A, Clinical and Molecular Teratology, 85, 102–107.
5. Berry, R. J., Bailey, L., Mulinare, J., Bower, C., & Folic Acid Working Group. (2010). Fortification of flour with folic acid. Food and Nutrition Bulletin, 31(1 Suppl), S22–S35.
6. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., … Correa, A. (1999). Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. The New England Journal of Medicine, 341, 1485–1490.
7. Blencowe, H., Kancherla, V., Moorthie, S., Darlison, M. W., & Modell, B. (2018). Estimates of global and regional prevalence of neural tube defects for 2015: A systematic analysis. Annals of the New York Academy of Sciences, 1414, 31–46.
8. Botto, L. D., Moore, C. A., Khoury, M. J., & Erickson, J. D. (1999). Neural-tube defects. The New England Journal of Medicine, 341, 1509–1519.
9. Castillo-Lancellotti, C., Tur, J. A., & Uauy, R. (2013). Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutrition, 16, 901–911.
10. Christianson, A., & Modell, B. (2006). March of Dimes global report on birth defects: The hidden toll of dying and disabled children. White Plains, NY: March of Dimes.
11. Cordero, A. M., Crider, K. S., Rogers, L. M., Cannon, M. J., & Berry, R. J. (2015). Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR. Morbidity and Mortality Weekly Report, 64, 421–423.
12. Crider, K. S., Devine, O., Hao, L., Dowling, N. F., Li, S., Molloy, A. M., … Berry, R. J. (2014). Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ (Clinical research ed), 349, g4554.
13. Czeizel, A. E., & Dudas, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. The New England Journal of Medicine, 327, 1832–1835.
14. Darmstadt, G. L., Howson, C. P., Walraven, G., Armstrong, R. W., Blencowe, H. K., Christianson, A. L., … for the Participant Working Group of the Dar es Salaam Seventh International Conference on Birth Defects and Disabilities in the Developing World. (2016). Prevention of congenital disorders and care of affected children: A consensus statement. JAMA Pediatrics, 170, 790–793.
15. De Wals, P., Tairou, F., Van Allen, M. I., Lowry, R. B., Evans, J. A., Van den Hof, M. C., … Niyonsenga, T. (2008). Spina bifida before and after folic acid fortification in Canada. Birth Defects Research. Part A, Clinical and Molecular Teratology, 82, 622–626.
16. Grosse, S. D., Berry, R. J., Tilford, J. M., Kucik, J. E., & Waitzman, N. J. (2016). Retrospective assessment of cost savings from prevention. Folic acid fortification and spina bifida in the U.S. American Journal of Preventive Medicine, 50(5 Suppl 1), S74–S80.
17. Grosse, S. D., Waitzman, N. J., Romano, P. S., & Mulinare, J. (2005). Reevaluating the benefits of folic acid fortification in the United States: Economic analysis, regulation, and public health. American Journal of Public Health, 95, 1917–1922.
18. Hoddinott, J. (2018). The investment case for folic acid fortification in developing countries. Annals of the New York Academy of Sciences, 1414, 72–81.
19. Kancherla, V., & Black, R. E. (2018). Historical perspective on folic acid and challenges in estimating global prevalence of neural tube defects. Annals of the New York Academy of Sciences, 1414, 20–30.
20. Kancherla, V., Druschel, C. M., & Oakley, G. P., Jr. (2014). Population-based study to determine mortality in spina bifida: New York State Congenital Malformations Registry, 1983 to 2006. Birth Defects Research. Part A, Clinical and Molecular Teratology, 100, 563–575.
21. Kancherla, V., & Oakley, G. P., Jr. (2018). Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India: Implications in achieving Target 3.2 of the sustainable development goals. Birth Defects Research, 110, 421–428.
22. MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet, 338, 131–137.
23. Oakeshott, P., Hunt, G. M., Poulton, A., & Reid, F. (2010). Expectation of life and unexpected death in open spina bifida: A 40-year complete, non-selective, longitudinal cohort study. Developmental Medicine and Child Neurology, 52, 749–753.
24. Oakley, G. P., Jr. (2009). The scientific basis for eliminating folic acid-preventable spina bifida: A modern miracle from epidemiology. Annals of Epidemiology, 19(4), 226–230.
25. Odewole, O. A., Williamson, R. S., Zakai, N. A., Berry, R. J., Judd, S. E., Qi, Y. P., … Oakley, G. P., Jr. (2013). Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for geographic and racial differences in stroke study 2003-2007. The American Journal of Clinical Nutrition, 98, 1042–1047.
26. Ouyang, L., Grosse, S. D., Armour, B. S., & Waitzman, N. J. (2007). Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Research. Part A, Clinical and Molecular Teratology, 79, 552–558.
27. Parfitt, J., Barthel, M., & Macnaughton, S. (2010). Food waste within food supply chains: Quantification and potential for change to 2050. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 365, 3065–3081.
28. Smith, M. A., & Lau, C. (2015). A resolution on folic acid fortification. Birth Defects Research. Part A, Clinical and Molecular Teratology, 103, 1–2.
29. Sutton, M., Daly, L. E., & Kirke, P. N. (2008). Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Research. Part A, Clinical and Molecular Teratology, 82, 701–709.
30. Wang, Y., Hu, J., Druschel, C. M., & Kirby, R. S. (2011). Twenty-five-year survival of children with birth defects in New York State: A population-based study. Birth Defects Research. Part A, Clinical and Molecular Teratology, 91, 995–1003.
31. Williams, J., Mai, C. T., Mulinare, J., Isenburg, J., Flood, T. J., Ethen, M., … Kirby, R. S. (2015). Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR. Morbidity and Mortality Weekly Report, 64, 1–5.
32. Yang, Q., Cogswell, M. E., Hamner, H. C., Carriquiry, A., Bailey, L. B., Pfeiffer, C. M., & Berry, R. J. (2010). Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. The American Journal of Clinical Nutrition, 91, 64–72.
33. Youngblood, M. E., Williamson, R., Bell, K. N., Johnson, Q., Kancherla, V., & Oakley, G. P., Jr. (2013). 2012 Update on global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research. Part A, Clinical and Molecular Teratology, 97, 658–663.